Novartis AG (NVS) CEO, a San Francisco Native, Takes an Axe to Predecessor's Empire
Google (GOOG)'s Mystery Biotech Calico Cuts Local Longevity R&D Pact
Why Your Last Investment Blew Up
In a Letter to Employees, Alcon (ACL) Chief Defends Company's Culture for Women
Number Of Births May Affect Mom's Future Heart Health, UT Southwestern Medical Center Study
Led By Ex-Elan (ELN) Execs, Malin Rakes in $350 Million and Looks to Invest in Viamet, Novan Therapeutics
Gilead (GILD)'s $600 Million Man
New Research Throws Cold Water on Biogen (BIIB)'s Recent Breakthrough
Population Genetics to Hire 30 As It Establishes U.S. Headquarters in Cleveland
More Job Cuts for Struggling GlaxoSmithKline (GSK), 180 Affected in North Carolina
Salix (SLXP) Had a $13 Billion Offer on the Table From Allergan (AGN) Before Accounting Problems Smashed Share Price
BioClinica, Inc. to Open Research Triangle Park Site, Hire Dozens
BioSpace (DHX) Temperature Poll: As GlaxoSmithKline (GSK) Leaves Philly, Will Pharm Country Stay Strong?
Boston Startup Semma Therapeutics Reels in $44 Million; In Process of Hiring and Leasing Lab Space
AstraZeneca PLC (AZN) Forms a Board of Outside Scientists to Review Trial Data Requests
10 Popular Products Not Endorsed By FDA
Emergent BioSolutions (EBS) Receives FDA Approval Of Anthrasil, Its Anthrax Immune Globulin, For Use In The Treatment Of Inhalational Anthrax
Gilead (GILD) Warns After Nine Hepatitis Patients Taking Heart Drug Develop Condition, One Dies From Cardiac Arrest
See All News >